We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Medical Grade Sensor Continuously Monitors Vital Signs

By HospiMedica International staff writers
Posted on 31 Mar 2020
A comprehensive and advanced tracking system monitors COVID-19 patient’s medical condition and deterioration from afar.

The Biobeat (Petach Tikva, Israel) platform allows continuous patient monitoring using a wireless, non-invasive, disposable optical sensor that measures 16 different vital signs, including cuffless blood pressure, heart rate, blood oxygen saturation (SpO2), respiratory rate, stroke volume, cardiac output, systemic vascular resistance, and temperature. More...
The data is automatically transmitted in real time to the cloud via the Biobeat app, and can be accessed from anywhere, providing relevant alerts when a change is detected.

The system dramatically reduces direct contact between patients and health care providers, decreasing the risk for secondary exposure of medical teams. Following the increase in cases, Israeli hospitals are preparing designated isolation units for infected patients. Biobeat has already installed the monitoring platform in 11 hospitals across the country, and will continue installing several more over the coming weeks. Biobeat is also working closely with several other authorities in Israel to implement monitoring of home hospitalized patients.

“This is the first time we can closely monitor individuals while keeping our healthcare providers safe, without compromising the medical support they provide,” said Professor Arik Eisenkraft, MD, chief medical officer of Biobeat. “We intend to use the valuable data gathered from monitored subjects to analyze the influence of the virus on humans and the effectiveness of the medical treatments given.”

As a result of increasing healthcare costs, an increasing aging population, and demonstrated improved patient outcomes with advanced remote monitoring technologies, healthcare providers are beginning to shift eligible patients toward home care programs. Remote and continuous monitoring have shown a reduction in readmissions, improved patient outcomes, and overall decrease in cost of care compared to a traditional hospital stay.

Related Links:
Biobeat


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Cardiograph Device
PageWriter TC35
Portable Jaundice Management Device
Nymphaea
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.